ADAMTS13 and von Willebrand factor are useful biomarkers for sorafenib treatment efficiency in patients with hepatocellular carcinoma

DOI: 10.4251/wjgo.v11.i5.424

Keywords: ADAMTS13, Von Willebrand factor, Biomarkers, Hepatocellular carcinoma, Sorafenib

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text